Heat Biologics Fundamentals

HTBX -  USA Stock  

USD 2.71  0.06  2.26%

Heat Biologics fundamentals help investors to digest information that contributes to Heat Biologics' financial success or failures. It also enables traders to predict the movement of Heat Biologics Stock. This fundamental analysis module provides a way for investors to measures Heat Biologics' intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heat Biologics stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Heat Biologics Fundamentals 

 
Refresh
Heat Biologics Interest Expense is fairly stable at the moment as compared to the past year. Heat Biologics reported Interest Expense of 631,813 in 2021. Selling General and Administrative Expense is likely to rise to about 18.5 M in 2022, whereas Consolidated Income is likely to drop (24.4 M) in 2022.

Heat Biologics Retained Earnings Analysis

Heat Biologics' Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
 2019 2020 2021 2022 (projected)
Current Assets15.21 M113.79 M130.86 M141.19 M
Total Assets25.96 M124.19 M142.82 M154.1 M
Retained Earnings 
 = 
Beginning RE + Income 
Dividends 
More About Retained Earnings | All Equity Analysis

Current Heat Biologics Retained Earnings

    
  (107.35 M)  
Most of Heat Biologics' fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heat Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Compare to competition

Heat Biologics Accumulated Retained Earnings Deficit

Accumulated Retained Earnings Deficit

(120.68 Million)Share
Heat Biologics Accumulated Retained Earnings Deficit are fairly stable at the moment as compared to the past year. Heat Biologics reported Accumulated Retained Earnings Deficit of (117.58 Million) in 2021
Based on the latest financial disclosure, Heat Biologics has a Retained Earnings of (107.35 Million). This is 111.53% lower than that of the Healthcare sector and 210.79% lower than that of the Biotechnology industry. The retained earnings for all United States stocks is 101.15% higher than that of the company.

Heat Biologics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Heat Biologics's current stock value. Our valuation model uses many indicators to compare Heat Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Heat Biologics competition to find correlations between indicators driving Heat Biologics's intrinsic value. More Info.
Heat Biologics is rated # 2 in retained earnings category among related companies. It is rated # 3 in shares owned by institutions category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Heat Biologics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Heat Biologics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Heat Biologics' earnings, one of the primary drivers of an investment's value.

Heat Biologics Current Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heat Biologics' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heat Biologics could also be used in its relative valuation, which is a method of valuing Heat Biologics by comparing valuation metrics of similar companies.
Heat Biologics is currently under evaluation in current ratio category among related companies.

Heat Biologics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Heat Biologics from analyzing Heat Biologics' financial statements. These drivers represent accounts that assess Heat Biologics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Heat Biologics' important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Average Assets16 M31.75 M28.5 M87.47 M100.59 M108.53 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(12.52 M)(16.48 M)(19.7 M)(25.62 M)(23.06 M)(23.67 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(12.52 M)(16.48 M)(19.7 M)(25.62 M)(23.06 M)(23.67 M)
Earnings before Tax(12.65 M)(16.72 M)(19.97 M)(26.05 M)(23.44 M)(24.06 M)
Average Equity9.41 M22.51 M19.78 M78.13 M89.85 M96.94 M
Enterprise Value9.34 M1.73 M6.85 M99.4 M114.31 M123.33 M
Free Cash Flow(6.46 M)(22.31 M)(12.99 M)(22.36 M)(20.12 M)(21.71 M)
Invested Capital(2.17 M)8.2 M8.56 M109.88 M126.36 M136.34 M
Invested Capital Average1.35 M3.07 M9.05 M63.4 M72.9 M78.66 M
Market Capitalization13.7 M22.79 M16.22 M122.4 M140.76 M151.87 M
Tangible Asset Value18 M35.57 M24.5 M122.74 M141.15 M152.3 M
Working Capital1.41 M23.84 M6.77 M110.14 M126.66 M136.66 M

Heat Biologics Fundamentals

About Heat Biologics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Heat Biologics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heat Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heat Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Deferred Revenue757.1 K777 K
Revenues3.4 M3.4 M
Heat Biologics, Inc., a biopharmaceutical company, engages in the development of immunotherapies to activate patients immune system against cancer through T-cell activation and expansion. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina. Heat Biologics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.

Heat Biologics Investors Sentiment

The influence of Heat Biologics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Heat Biologics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Heat Biologics Implied Volatility

    
  152.16  
Heat Biologics' implied volatility exposes the market's sentiment of Heat Biologics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Heat Biologics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Heat Biologics stock will not fluctuate a lot when Heat Biologics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Heat Biologics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Heat Biologics' short interest history, or implied volatility extrapolated from Heat Biologics options trading.

Current Sentiment - HTBX

Heat Biologics Investor Sentiment

Most of Macroaxis users are currently bullish on Heat Biologics. What is your judgment towards investing in Heat Biologics? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Heat Biologics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Heat Biologics Piotroski F Score and Heat Biologics Altman Z Score analysis. Note that the Heat Biologics information on this page should be used as a complementary analysis to other Heat Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Heat Biologics Stock analysis

When running Heat Biologics price analysis, check to measure Heat Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heat Biologics is operating at the current time. Most of Heat Biologics' value examination focuses on studying past and present price action to predict the probability of Heat Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Heat Biologics' price. Additionally, you may evaluate how the addition of Heat Biologics to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Is Heat Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heat Biologics. If investors know Heat Biologics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heat Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Heat Biologics is measured differently than its book value, which is the value of Heat Biologics that is recorded on the company's balance sheet. Investors also form their own opinion of Heat Biologics' value that differs from its market value or its book value, called intrinsic value, which is Heat Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heat Biologics' market value can be influenced by many factors that don't directly affect Heat Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heat Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine Heat Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heat Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.